IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 217 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $41 | -36.9% | 9,052 | -1.5% | 0.00% | -33.3% |
| Q2 2023 | $65 | +16.1% | 9,194 | -0.6% | 0.00% | +50.0% |
| Q1 2023 | $56 | -5.1% | 9,247 | -0.4% | 0.00% | -33.3% |
| Q4 2022 | $59 | -99.9% | 9,280 | -16.9% | 0.00% | -25.0% |
| Q3 2022 | $107,000 | -31.4% | 11,164 | -20.8% | 0.00% | -20.0% |
| Q2 2022 | $156,000 | -33.3% | 14,088 | +0.2% | 0.01% | -16.7% |
| Q1 2022 | $234,000 | -24.0% | 14,065 | -12.9% | 0.01% | 0.0% |
| Q4 2021 | $308,000 | -22.2% | 16,147 | +0.5% | 0.01% | -33.3% |
| Q3 2021 | $396,000 | -9.2% | 16,069 | -4.1% | 0.01% | +12.5% |
| Q2 2021 | $436,000 | -25.2% | 16,759 | +33.3% | 0.01% | -33.3% |
| Q4 2020 | $583,000 | +181.6% | 12,574 | +100.1% | 0.01% | +140.0% |
| Q3 2020 | $207,000 | – | 6,283 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,876,600 | $127,618,000 | 11.48% |
| Fairmount Funds Management LLC | 596,890 | $19,650,000 | 8.32% |
| Ghost Tree Capital, LLC | 575,000 | $18,929,000 | 5.47% |
| Perceptive Advisors | 10,085,632 | $332,019,000 | 4.85% |
| Avoro Capital Advisors LLC | 9,536,039 | $313,926,000 | 4.46% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $43,224,000 | 3.88% |
| ACUTA CAPITAL PARTNERS, LLC | 315,000 | $10,370,000 | 2.82% |
| Orbimed Advisors | 6,645,100 | $218,757,000 | 2.75% |
| QVT Financial LP | 572,971 | $18,862,000 | 2.30% |
| Prosight Management, LP | 120,606 | $3,970,000 | 1.89% |